0
Human Trials for Injury Recovery
the use it's actually sold for — muscle/tendon/joint — has none
3
Conditions With Real Human Trials
leg ulcers, dry eye, corneal healing — as thymosin β-4, topical/eye drops
Banned
WADA Since 2012 + FDA Restricted
prohibited in all sport; FDA "significant safety risk" list (2023)
$40-100
Per 5 mg Vial (Gray Market)
research-chemical only; purity & sterility unverified
How Strong Is the Proof — By Use?
PubMed · Honest ReadHere's the catch most sellers won't tell you: "TB-500" returns zero results on PubMed. All the real research is on its parent peptide, thymosin β-4 (Tβ4) — and the human trials that exist are for eye and skin conditions, given as eye drops or topical gel. For the thing people actually inject it for — muscle, tendon and joint recovery — the human evidence is essentially zero. This chart sets that straight up front.
What TB-500 Actually Does
PubMed · How It WorksThymosin β-4 is a natural 43-amino-acid peptide your own platelets and immune cells release after an injury. Its biology is genuinely interesting — the question is whether injecting a synthetic fragment reproduces it.
Moves Repair Cells
Actin-Binding
Tβ4's core trick: it binds actin and drives cell migration — mobilizing stem/progenitor cells to the injury so they can rebuild tissue. This is the mechanism behind every healing claim.
Builds Blood Vessels
Angiogenesis
It promotes new blood-vessel growth, feeding healing tissue. Useful for a wound — but the same property is why there's a theoretical concern about feeding a tumor (see Side Effects).
Calms & De-scars
Anti-Fibrotic
Reduces inflammation, apoptosis (cell death), and cuts the number of myofibroblasts — meaning less scar tissue and fibrosis. This is the most compelling part of the preclinical story.
"TB-500" ≠ the trial drug
Fragment
Important: gray-market "TB-500" is usually a short synthetic FRAGMENT (the LKKTETQ actin-binding region), not the full Tβ4 used in the human trials. So even the real Tβ4 data doesn't fully transfer to what's in the vial.
What the Human Research Actually Says
PubMed · By ConditionThymosin β-4 has been in real human trials — but read the right-hand column carefully, because the conditions with evidence are not the ones people buy TB-500 for.
| # | Use / Study | How Given | Where It Stands |
|---|---|---|---|
| 1 | Neurotrophic keratopathy (non-healing corneal wounds) |
Eye drops | STRONGEST HUMAN SIGNAL |
| 2 | Severe / moderate dry eye disease |
Eye drops | MIXED — Phase 2 yes, Phase 3 missed |
| 3 | Venous (leg) stasis ulcers |
Topical gel | PROMISING — small, early |
| 4 | Heart attack & tissue regeneration |
Injection (animal) | PRECLINICAL ONLY |
| 5 | Muscle, tendon, ligament & joint injury |
Injection (DIY) | NO HUMAN DATA |
The honest bottom line: the human evidence for thymosin β-4 is real but narrow — eye drops and topical gel for the eye and skin, where it's never even been FDA-approved. For the injectable "heal my tendon faster" use that TB-500 is sold for, there is no human trial evidence at all — only animal data, horse-racing use, and personal testimony. That's not the same as "it doesn't work," but you'd be an experiment of one.
The "Wolverine Stack" (TB-500 + BPC-157)
Community ProtocolPhil asked about this one specifically — it's the most famous peptide combo in the injury-recovery world. Two repair peptides stacked together, nicknamed after the Marvel character who heals from anything.
🪩 The Wolverine Stack
The idea: hit two different parts of the healing cascade at once. The metaphor people use — one builds the roads, the other sends the crew.
BPC-157 — "the roads"
Builds new blood vessels, ramps up growth-factor signaling and collagen at the injury site — creating the conditions for repair. (We have a full BPC-157 infographic.)
TB-500 — "the crew"
Mobilizes and migrates the repair cells to the site and tamps down inflammation — so the cells that do the actual rebuilding can get there.
The honest verdict: the mechanisms really are complementary, and the anecdotes (athletes, lifters, Joe Rogan calling BPC-157 "Wolverine shit" after a tendon recovery) are enthusiastic. But there is no human trial of the combination — zero. BPC-157 itself has ~35 animal studies and one small 12-person human trial; TB-500 has none for injury. The stack is a reasonable hypothesis built on two preclinical stories — not a proven protocol. Both are also banned in every drug-tested sport.
Cost vs Other Recovery Options
Market Data · US 2026For a stubborn tendon or joint injury — the reason people reach for TB-500 — here's how it stacks up against options that actually have human evidence behind them.
Most Proven
Physical Therapy
$50-150
per session
Strongest evidence
The first-line, best-studied path for most soft-tissue injury
The first-line, best-studied path for most soft-tissue injury
PRP Injection
$500-2000
per treatment
Doctor-given
Mixed but real human evidence for tendon/joint
Mixed but real human evidence for tendon/joint
Research Chem
TB-500 (alone)
$40-100
per 5 mg vial
~$5-8/mg
Cheap, but no human injury data + gray market
Cheap, but no human injury data + gray market
Research Chem
Wolverine Stack (12-wk)
$160-320
per cycle (TB-500 + BPC-157)
Blend ~$80-160/vial
Popular, but unproven in humans
Popular, but unproven in humans
Cortisone Injection
$50-250
per shot, often covered
FDA-approved
Fast relief, evidence-backed, doctor-given
Fast relief, evidence-backed, doctor-given
Regulatory Position
T1 · Official AgenciesFDA (USA)
Not approved — flagged as a risk
TB-500 / thymosin β-4 is not FDA-approved for any human use. In Oct 2023 the FDA placed it on the Category 2 list of "bulk drug substances that raise significant safety risks," and it stayed restricted when other peptides were cleared in 2024. Sold only as a research chemical.
WADA / Pro Sport
Banned at all times since 2012
Prohibited under S2 (peptide hormones/growth factors), in and out of competition, since Jan 1, 2012. The NFL, NBA, MLB, NHL and NCAA all ban it. Detection window ~30-45 days. A positive test ends seasons.
Horse Racing
Banned — and where it started
TB-500 was actually developed for veterinary use and surfaced in horse-racing doping cases in the early 2010s before human "biohackers" adopted it. It's now banned across competitive racing worldwide.
PubMed vs. the Doctors
Named Clinicians + Researchers
Two voices worth hearing: the researchers who built the actual science, and the credentialed doctors who discuss these peptides with real-world patients — set against what the controlled literature shows.
Dr. Allan L. Goldstein
PhD · George Washington University · discovered the thymosins
The scientist who discovered thymosin β-4 and authored the foundational review of its biology. His work is why we know Tβ4 binds actin, moves repair cells, and reduces scarring — the real, sober version of every claim on the sales pages.
vs. PubMed: his own reviews are careful to say the clinical applications are "ongoing and projected" trials — promise, not proof. The science is his; the hype isn't.
Dr. Ashley Froese
MD · Board-certified Family Medicine · Direct Primary Care
A peptide-focused physician whose channel "This Is Not Covered" has in-depth explainers on exactly these compounds — including "BPC 157 & TB-500: The Simple Explanation" and a full breakdown of the Wolverine stack. Notably, she models the same honesty this page is built on: one of her videos is titled "I Was WRONG About The Wolverine Stack," and another takes the cancer question head-on.
vs. PubMed: she's enthusiastic about the mechanisms but lands where the literature does — the human evidence for the injury use isn't there yet. Watch a credentialed doctor walk through it, then weigh it against the data above.
Side Effects & Who Should Be Careful
SafetyThe honest risk picture: the narrow eye/skin trials were well-tolerated at their doses, but that tells you little about injecting a gray-market fragment for months.
Reported & mild
In the formal trials, Tβ4 was well-tolerated — no significant adverse events at the doses studied. DIY injectors report injection-site reactions, head-rush/fatigue, and temporary lethargy. Human safety data outside the eye/skin trials is thin.
The theoretical cancer concern
Because it drives angiogenesis and cell migration, there's a legitimate theoretical worry it could feed an existing tumor or help cancer cells spread. Not proven in people — but it's why anyone with a cancer history should steer clear.
Gray-market & bans
It's an unregulated research chemical — purity, sterility and actual dose are unverified, and self-injection adds contamination/infection risk. It's also banned in all drug-tested sport (detectable 30-45 days) and is not for pregnancy/breastfeeding.
The plain-English risk: the biggest hazards aren't a known toxicity — they're the unknowns. No long-term human safety data, a real (if theoretical) cancer-promotion mechanism, and a gray-market supply where you can't be sure what's in the vial. That's a very different risk profile from a cheap, well-studied supplement.
New to TB-500? Start Here.
TB-500 is a lab-made copy of part of thymosin β-4, a natural healing peptide your body makes after an injury. People inject it (often with BPC-157, the "Wolverine stack") hoping to heal tendons, muscles and joints faster. The biology is real and interesting — but the human proof is for eye drops and skin gel, not the injectable injury use it's sold for, and it's banned in sport and unapproved by the FDA. Here's the honest tour.
What it is
A synthetic fragment of thymosin β-4, a 43-amino-acid peptide. Sold as a gray-market injectable "research chemical," usually as the actin-binding piece — not the full peptide used in trials.
What it does
Moves repair cells to an injury, builds blood vessels, and reduces inflammation and scarring — demonstrated in dishes and animals, plus narrow human eye/skin trials.
How people use it
Subcutaneous injection, often a "loading" phase then maintenance, frequently stacked with BPC-157. All off-label, DIY, and not medical advice.
Is it legal?
Sold only "for research." Not FDA-approved, on the FDA's significant-risk list, and banned in all drug-tested sport since 2012. Possessing/using it for yourself is a gray area; competing on it is a violation.
Should you try it?
Your call — this page won't make it. If you do: know there's no human injury data, the supply is unregulated, and there's a theoretical cancer concern. For most injuries, PT (and sometimes PRP) have far more evidence. Talk to a doctor — ideally one who knows peptides.
Common Questions, Honest Answers
The questions people actually ask about TB-500 — answered plainly.
Does it actually heal injuries faster?
In animals and in plenty of personal stories, yes. In human trials for injuries, there is no evidence either way — none have been run. The real human trials are for dry eye and corneal/skin wounds, given as drops and gel, not injections for tendons.
Is the "Wolverine stack" (with BPC-157) better than one alone?
The mechanisms are complementary and the anecdotes are loud, but no human trial of the combination exists. It's a smart-sounding hypothesis stacked on two preclinical stories — not a proven protocol.
Why isn't it FDA-approved if it's been studied for decades?
The studied formulations (eye drops, topical gel) are still working through trials — and some Phase 3s missed their targets. The injectable "TB-500" you can buy was never the thing being trialed; it's a research chemical riding on its parent peptide's reputation.
Will it make me fail a drug test?
Yes. It's WADA-prohibited at all times and banned by the major leagues and NCAA, detectable for roughly 30-45 days. If you compete in anything drug-tested, this ends it.
What's the single biggest risk?
The unknowns: no long-term human safety data, a real theoretical cancer-promotion mechanism (it grows blood vessels and moves cells), and a gray-market supply where purity and sterility aren't guaranteed.
Key Takeaways
- "TB-500" has zero PubMed results — the science is all thymosin β-4, and the human trials are for eye and skin, not injuries.
- The strongest human signal is corneal healing (Phase 3: 60% vs 12.5% placebo) — as eye drops, not injections.
- Heart/tissue regeneration data is striking but preclinical (mice).
- For the muscle/tendon/joint use it's sold for, there is no human trial evidence — only animals, horses, and testimony.
- The Wolverine stack (with BPC-157) has complementary mechanisms but no human combination trial.
- Not FDA-approved, FDA-flagged as a risk, and WADA-banned since 2012. Theoretical cancer concern + gray-market purity are the real risks.